Cubist Systematic Strategies LLC Invests $241,000 in Cardlytics, Inc. (NASDAQ:CDLX)

Cubist Systematic Strategies LLC acquired a new position in shares of Cardlytics, Inc. (NASDAQ:CDLXFree Report) in the fourth quarter, HoldingsChannel.com reports. The institutional investor acquired 64,912 shares of the company’s stock, valued at approximately $241,000.

A number of other hedge funds have also modified their holdings of CDLX. Mirabella Financial Services LLP purchased a new position in shares of Cardlytics during the 4th quarter worth approximately $4,285,000. Rangeley Capital LLC purchased a new position in shares of Cardlytics during the 4th quarter worth approximately $1,187,000. RBF Capital LLC increased its stake in shares of Cardlytics by 64.7% during the 4th quarter. RBF Capital LLC now owns 803,763 shares of the company’s stock worth $2,982,000 after purchasing an additional 315,635 shares in the last quarter. Natixis purchased a new position in shares of Cardlytics during the 4th quarter worth approximately $462,000. Finally, Bridgeway Capital Management LLC purchased a new position in shares of Cardlytics during the 4th quarter worth approximately $416,000. 68.10% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other news, CFO Alexis Desieno sold 24,778 shares of the business’s stock in a transaction on Tuesday, February 18th. The shares were sold at an average price of $3.40, for a total transaction of $84,245.20. Following the completion of the sale, the chief financial officer now directly owns 140,948 shares of the company’s stock, valued at $479,223.20. The trade was a 14.95% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Amit Gupta sold 46,857 shares of the business’s stock in a transaction on Tuesday, February 18th. The shares were sold at an average price of $3.40, for a total transaction of $159,313.80. Following the sale, the chief executive officer now directly owns 418,637 shares of the company’s stock, valued at $1,423,365.80. This represents a 10.07% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 71,938 shares of company stock valued at $244,017 in the last ninety days. Company insiders own 4.40% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have commented on CDLX shares. Evercore ISI lowered their target price on shares of Cardlytics from $4.00 to $3.00 and set an “in-line” rating for the company in a research note on Thursday, March 13th. Lake Street Capital lowered their target price on shares of Cardlytics from $3.00 to $2.50 and set a “hold” rating for the company in a research note on Thursday, May 8th. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of Cardlytics in a research note on Thursday, March 13th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $5.20.

Read Our Latest Stock Report on CDLX

Cardlytics Stock Up 3.5%

Shares of NASDAQ CDLX opened at $2.06 on Friday. Cardlytics, Inc. has a 52-week low of $1.22 and a 52-week high of $9.85. The firm has a fifty day moving average of $1.81 and a 200-day moving average of $2.90. The stock has a market capitalization of $108.15 million, a PE ratio of -0.34 and a beta of 1.30. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 2.40.

Cardlytics Profile

(Free Report)

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.

Featured Stories

Want to see what other hedge funds are holding CDLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardlytics, Inc. (NASDAQ:CDLXFree Report).

Institutional Ownership by Quarter for Cardlytics (NASDAQ:CDLX)

Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.